Skip to main content
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.46
-0.08 (-1.44%)
At close: Apr 28, 2026, 4:00 PM EDT
5.50
+0.04 (0.73%)
Pre-market: Apr 29, 2026, 5:31 AM EDT

Verastem Revenue

In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth. Verastem had revenue of $17.54M in the quarter ending December 31, 2025.

Revenue (ttm)
$30.91M
Revenue Growth
+209.14%
P/S Ratio
15.51
Revenue / Employee
$303,078
Employees
102
Market Cap
479.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 418.63M
ADC Therapeutics 81.36M
Fulcrum Therapeutics 80.00M
Upstream Bio 2.85M
Lyell Immunopharma 36.00K
Revenue Rankings

VSTM News

More News